Camelot Portfolios LLC Sells 55 Shares of Cardinal Health, Inc. (CAH)
Camelot Portfolios LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH) by 1.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 4,250 shares of the company’s stock after selling 55 shares during the period. Camelot Portfolios LLC’s holdings in Cardinal Health were worth $331,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of the company. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after buying an additional 17 shares during the last quarter. HL Financial Services LLC boosted its stake in Cardinal Health by 0.3% in the first quarter. HL Financial Services LLC now owns 11,887 shares of the company’s stock worth $969,000 after buying an additional 38 shares in the last quarter. Edmond DE Rothschild Holding S.A. boosted its stake in Cardinal Health by 0.9% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,321 shares of the company’s stock worth $353,000 after buying an additional 39 shares in the last quarter. Private Trust Co. NA boosted its stake in Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock worth $1,119,000 after buying an additional 41 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in Cardinal Health by 1.2% in the second quarter. Bessemer Group Inc. now owns 4,238 shares of the company’s stock worth $330,000 after buying an additional 51 shares in the last quarter. 87.09% of the stock is currently owned by institutional investors.
Shares of Cardinal Health, Inc. (NYSE:CAH) opened at 69.14 on Monday. Cardinal Health, Inc. has a 52-week low of $62.70 and a 52-week high of $84.90. The stock has a market capitalization of $21.85 billion, a PE ratio of 17.16 and a beta of 0.80. The company’s 50 day moving average price is $77.38 and its 200 day moving average price is $77.27.
Cardinal Health (NYSE:CAH) last announced its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. During the same period in the previous year, the business earned $1.14 EPS. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. On average, equities research analysts anticipate that Cardinal Health, Inc. will post $5.07 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This story was first reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/08/07/camelot-portfolios-llc-sells-55-shares-of-cardinal-health-inc-cah.html.
A number of equities research analysts have recently commented on the company. UBS AG reissued a “neutral” rating and issued a $76.00 target price (down from $79.00) on shares of Cardinal Health in a research note on Thursday. Credit Suisse Group reissued an “outperform” rating and issued a $87.00 target price (up from $81.00) on shares of Cardinal Health in a research note on Thursday, July 13th. William Blair cut Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Barclays PLC reissued an “overweight” rating and issued a $82.00 target price (down from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. Finally, BidaskClub cut Cardinal Health from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the company. Cardinal Health presently has an average rating of “Hold” and an average price target of $80.46.
In related news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the business’s stock in a transaction on Friday, May 12th. The stock was sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the transaction, the insider now directly owns 55,440 shares in the company, valued at approximately $4,039,912.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.94% of the stock is owned by insiders.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.